{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:29:47Z","timestamp":1793982587645,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017R1D1A1B03031642"],"award-info":[{"award-number":["NRF-2017R1D1A1B03031642"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1277-2","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T19:08:43Z","timestamp":1552504123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of steroids and relevant cytokine analysis in acute tubulointerstitial nephritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Donghwan","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Nam","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jun","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-5261","authenticated-orcid":false,"given":"Seung Seok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"3","key":"1277_CR1","first-page":"221","volume":"70","author":"K Farrington","year":"1989","unstructured":"Farrington K, et al. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med. 1989;70(3):221\u201333.","journal-title":"Q J Med"},{"issue":"3","key":"1277_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0272-6386(00)70196-X","volume":"35","author":"M Haas","year":"2000","unstructured":"Haas M, et al. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000;35(3):433\u201347.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1277_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5414\/CN108301","volume":"81","author":"MA Perazella","year":"2014","unstructured":"Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol. 2014;81(6):381\u20138.","journal-title":"Clin Nephrol"},{"issue":"9","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ndt\/gfu326","volume":"30","author":"M Praga","year":"2015","unstructured":"Praga M, et al. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015;30(9):1472\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"1277_CR5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ki.2010.89","volume":"77","author":"M Praga","year":"2010","unstructured":"Praga M, Gonzalez E. Acute interstitial nephritis. Kidney Int. 2010;77(11):956\u201361.","journal-title":"Kidney Int"},{"issue":"5","key":"1277_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cgh.2005.11.004","volume":"4","author":"N Geevasinga","year":"2006","unstructured":"Geevasinga N, et al. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol. 2006;4(5):597\u2013604.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1277_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ndt\/gfs318","volume":"28","author":"AS Bomback","year":"2013","unstructured":"Bomback AS, Markowitz GS. Increased prevalence of acute interstitial nephritis: more disease or simply more detection? Nephrol Dial Transplant. 2013;28(1):16\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5414\/CN10838","volume":"82","author":"R Raghavan","year":"2014","unstructured":"Raghavan R, Eknoyan G. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 2014;82(3):149\u201362.","journal-title":"Clin Nephrol"},{"issue":"2","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1523-1755.2001.060002804.x","volume":"60","author":"J Rossert","year":"2001","unstructured":"Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001;60(2):804\u201317.","journal-title":"Kidney Int"},{"issue":"5","key":"1277_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/0971-4065.147766","volume":"25","author":"R Ramachandran","year":"2015","unstructured":"Ramachandran R, et al. Drug-induced acute interstitial nephritis: a clinicopathological study and comparative trial of steroid regimens. Indian J Nephrol. 2015;25(5):281\u20136.","journal-title":"Indian J Nephrol"},{"issue":"11","key":"1277_CR11","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","volume":"19","author":"MR Clarkson","year":"2004","unstructured":"Clarkson MR, et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004;19(11):2778\u201383.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonzalez","year":"2008","unstructured":"Gonzalez E, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int. 2008;73(8):940\u20136.","journal-title":"Kidney Int"},{"issue":"8","key":"1277_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1440-1797.2012.01648.x","volume":"17","author":"MN Raza","year":"2012","unstructured":"Raza MN, et al. Acute tubulointerstitial nephritis, treatment with steroid and impact on renal outcomes. Nephrology (Carlton). 2012;17(8):748\u201353.","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"1277_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi AK, et al. Biopsy-proven acute interstitial nephritis, 1993-2011: a case series. Am J Kidney Dis. 2014;64(4):558\u201366.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1277_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/qjmed\/hcu236","volume":"108","author":"A Valluri","year":"2015","unstructured":"Valluri A, et al. Acute tubulointerstitial nephritis in Scotland. Q J Med. 2015;108(7):527\u201332.","journal-title":"Q J Med"},{"issue":"2","key":"1277_CR16","first-page":"233","volume":"10","author":"M Prendecki","year":"2017","unstructured":"Prendecki M, et al. Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids. Clin Kidney J. 2017;10(2):233\u20139.","journal-title":"Clin Kidney J"},{"issue":"7","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ndt\/gfx247","volume":"33","author":"T Su","year":"2018","unstructured":"Su T, et al. Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China. Nephrol Dial Transplant. 2018;33(7):1180\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","volume":"55","author":"LC Racusen","year":"1999","unstructured":"Racusen LC, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55(2):713\u201323.","journal-title":"Kidney Int"},{"issue":"9","key":"1277_CR19","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.162.9.5506","volume":"162","author":"MA Daemen","year":"1999","unstructured":"Daemen MA, et al. Ischemia\/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol. 1999;162(9):5506\u201310.","journal-title":"J Immunol"},{"issue":"4","key":"1277_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1523-1755.2002.kid577.x","volume":"62","author":"FL Sung","year":"2002","unstructured":"Sung FL, et al. Enhanced MCP-1 expression during ischemia\/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int. 2002;62(4):1160\u201370.","journal-title":"Kidney Int"},{"issue":"1","key":"1277_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clim.2006.09.008","volume":"123","author":"JM Thurman","year":"2007","unstructured":"Thurman JM. Triggers of inflammation after renal ischemia\/reperfusion. Clin Immunol. 2007;123(1):7\u201313.","journal-title":"Clin Immunol"},{"issue":"11","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1172\/JCI119457","volume":"99","author":"M Takada","year":"1997","unstructured":"Takada M, et al. The cytokine-adhesion molecule cascade in ischemia\/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest. 1997;99(11):2682\u201390.","journal-title":"J Clin Invest"},{"issue":"2","key":"1277_CR23","first-page":"20","volume":"4","author":"M Malek","year":"2015","unstructured":"Malek M, Nematbakhsh M. Renal ischemia\/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev. 2015;4(2):20\u20137.","journal-title":"J Renal Inj Prev"},{"issue":"6","key":"1277_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/cs0940557","volume":"94","author":"PJ Barnes","year":"1998","unstructured":"Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998;94(6):557\u201372.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2215\/CJN.01711105","volume":"1","author":"DC Preddie","year":"2006","unstructured":"Preddie DC, et al. Mycophenolate mofetil for the treatment of interstitial nephritis. Clin J Am Soc Nephrol. 2006;1(4):718\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"32","key":"1277_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001366","volume":"94","author":"BA McMahon","year":"2015","unstructured":"McMahon BA, et al. Rituximab for the treatment of IgG4-related Tubulointerstitial nephritis: case report and review of the literature. Medicine (Baltimore). 2015;94(32):e1366.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1277_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044266","volume":"7","author":"FS Lichtenegger","year":"2012","unstructured":"Lichtenegger FS, et al. CD86 and IL-12p70 are key players for T helper 1 polarization and natural killer cell activation by toll-like receptor-induced dendritic cells. PLoS One. 2012;7(9):e44266.","journal-title":"PLoS One"},{"issue":"3","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"G612","DOI":"10.1152\/ajpgi.90576.2008","volume":"296","author":"EC Ebert","year":"2009","unstructured":"Ebert EC. Infliximab and the TNF-alpha system. Am J Physiol Gastrointest Liver Physiol. 2009;296(3):G612\u201320.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"13","key":"1277_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"KA Papp","year":"2012","unstructured":"Papp KA, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366(13):1181\u20139.","journal-title":"N Engl J Med"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1277-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T13:20:29Z","timestamp":1694697629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1277-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"21 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study design was approved by the institutional review boards of all involved centers (nos. H-1801-043-914, B-1801\/447\u2013409, and 20,180,124\/30\u20132018-3\/023) and complied with the Declaration of Helsinki. Informed consents were waived under this approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"88"}}